"Designing Growth Strategies is in our DNA"

Spinal Muscular Atrophy (SMA) Treatment Market Size, Share & Industry Analysis, By Product (Nusinersen and Onasemnogen Abeparvovec), By Disease Type (Type 1 SMA, Type 2 SMA and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Others), and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI100576

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Spinal Muscular Atrophy for Key Countries
    2. Key Industry Developments
    3. Pipeline Analysis
    4. New Product Launches
    5. Reimbursement Scenario by Key Countries
    6. Regulatory Scenario
    7. Key Industry Trends
  5. Global Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis, Insights and Forecast – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
    5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Analysis, Insights and Forecast, 2017-2026
    1. Key Findings / Summary
    2. Market Analysis – By Product Type
      1. Nusinersen
      2. Onasemnogen Abeparvovec
    3. Market Analysis – By Disease Type
      1. Type 1 SMA
      2. Type 2 SMA
      3. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Others
  10. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles
      1. Biogen
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Genentech, Inc./ F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Astellas Pharma Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Genzyme Corporation
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Figure 1:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018 & 2026

Figure 3:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Nusinersen, 2015-2026

Figure 4:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Onasemnogen Abeparvovec, 2015-2026

Figure 5:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018 & 2026

Figure 6:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Type 1 SMA, 2015-2026

Figure 7:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Type 2 SMA, 2015-2026

Figure 8:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 9:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 10:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 11:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 12:  Global Spinal Muscular Atrophy (SMA) Treatment Market Forecast (US$ Mn), by Others, 2015-2026

Figure 13:  Global Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Region, 2018 & 2026

Figure 14:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 15:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 16:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 17:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 18:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 19:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 20:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country, 2018 & 2026

Figure 21:  North America Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country, 2018

Figure 22:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 23:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 24:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 25:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 26:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 27:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 28:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 29:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 30:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 31:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 32:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 33:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 34:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 35:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 36:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 37:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 38:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Product, 2018 & 2026

Figure 39:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Product, 2018

Figure 40:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Disease Type, 2018 & 2026

Figure 41:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Disease Type, 2018

Figure 42:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 43:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), by Distribution Channel, 2018

Figure 44:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 45:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Value Share (%), By Country/ Sub-region, 2018

Figure 46:  Global Spinal Muscular Atrophy (SMA) Treatment Market Share (%), By Company, 2018

Table 1:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015–2026

Table 2:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015–2026

Table 3:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 6:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 7:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 10:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 11:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 14:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 15:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Product, 2015-2026

Table 18:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Disease Type, 2015-2026

Table 19:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Rest of the World Spinal Muscular Atrophy (SMA) Treatment Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Booklet
  • Mar, 2020
  • 2018
  • 2015-2017
  • 120

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Compare Licenses Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X